Status:
COMPLETED
Porcine Acellular Dermal Matrix for the Treatment of Localized Gingival Recessions
Lead Sponsor:
University of Campinas, Brazil
Conditions:
Gingival Recession
Eligibility:
All Genders
18-60 years
Phase:
NA
Brief Summary
Aim: The aim of this randomized clinical trial is to evaluate the use of the porcine acellular dermal matrix (PADM) for the treatment of RT1 localized gingival recessions. Material and methods: Forth...
Eligibility Criteria
Inclusion
- RT1 localized gingival recessions with height ranging from 3 to 5 mm;
- 2mm or more of keratinized tissue width ;
- Probing depth less than 3mm;
- Plaque and gingival index less or equal to 20%.
Exclusion
- Smokers;
- Pregnants;
- Nursing;
- Patients with diabetes mellitus or another condition that interfere in the tissue repair
- Patients who use drugs or medications that interfere in the tissue repair;
- Allergies to any composition of the devices of the study.
Key Trial Info
Start Date :
September 10 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 30 2024
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT06006780
Start Date
September 10 2022
End Date
December 30 2024
Last Update
April 2 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Piracicaba Dental School, State University of Campinas
Piracicaba, São Paulo, Brazil, 13414-903